Episode 423: Understanding Infections and MS with Dr. Robert Fox
RealTalk MS6 Okt 2025

Episode 423: Understanding Infections and MS with Dr. Robert Fox

From the earliest days of the COVID-19 pandemic, people living with MS have been justifiably concerned about how a COVID-19 infection might impact their MS. As the new "Stratus" strain of COVID-19 is currently surging in the United States, research is providing answers we didn't have five years ago.

Dr. Robert Fox, the Managing Director of the NARCOMS Patient Registry, joins me to discuss how COVID-19 infections and other infections impact people with MS.

As ECTRIMS, the world's largest MS research conference, approached, many attendees anticipated the FDA's decision on whether to approve Tolebrutinib, the first in a new category of disease-modifying therapies. Instead, the FDA has requested additional time for its review. We'll fill you in on the FDA's new target action date, and explain why there's strong interest in this particular disease-modifying therapy.

We know there's a specific gene that increases the risk of someone developing MS. But have you ever wondered where that gene came from, or why it exists at all? At ECTRIMS, Professor Lars Fugger took us on a journey 5,000 years into the past to explain its origin. When I spoke with him, Professor Fugger also explained how events from ancient history are still affecting the risk of developing MS today. You won't want to miss this compelling conversation!

At ECTRIMS, I also caught up with Jason Tardio, the President, and Dr. Andreas Muehler, the Chief Medical Officer, from Immunic Therapeutics. We talked about how their investigative drug, vidofludimus calcium, could potentially benefit people with MS by combating inflammation, protecting the nervous system, and offering antiviral benefits.

We have a lot to talk about! Are you ready for RealTalk MS??!

This Week: Infections and MS, and more from ECTRIMS 2025! :22

FDA extends its review of Tolebrutinib 1:42

From ECTRIMS: Professor Lars Fugger discusses the origin of the gene that increases an individual's risk of developing MS 4:11

From ECTRIMS: Jason Tardio, President, and Dr. Andreas Muehler, Chief Medical Officer, at Immunic Therapeutics, discuss how vidofludimus calcium could potentially benefit people with MS 11:22

Dr. Robert Fox discusses what the research reveals about how COVID-19 infections and other infections impact people living with MS 16:34

Share this episode 32:00

Next week's episode 32:19

SHARE THIS EPISODE OF REALTALK MS

Just copy this link & paste it into your text or email: https://realtalkms.com/423

ADD YOUR VOICE TO THE CONVERSATION

I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!

Email: jon@realtalkms.com
Phone: (310) 526-2283

And don't forget to join us in the RealTalk MS Facebook group!

LINKS

If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com

PARTICIPATE: Take the Shaping Tomorrow Together Survey
https://s.alchemer.com/s3/Perspectives-on-MS

REGISTER: Attend the virtual Shaping Tomorrow Together meeting with the FDA
https://nmss.quorum.us/event/25463

SIGN UP: Become an MS Activist
https://nationalmssociety.org/advocacy

JOIN: The RealTalk MS Facebook Group
https://facebook.com/groups/realtalkms

DOWNLOAD: The RealTalk MS App for iOS Devices
https://itunes.apple.com/us/app/realtalk-ms/id1436917200

DOWNLOAD: The RealTalk MS App for Android Devices
https://play.google.com/store/apps/details?id=tv.wizzard.android.realtalk

REVIEW: Give RealTalk MS a rating and review
http://www.realtalkms.com/review

Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.

RealTalk MS Episode 423
Guests: Professor Lars Fugger, Jason Tardio, Dr. Andreas Meuhler, and Dr. Robert Fox

Privacy Policy

Avsnitt(504)

Episode 415: Your Money -- Ways to Earn and Hold Onto More of It When You're Living with MS with Beth Scott and Paula Cole

Episode 415: Your Money -- Ways to Earn and Hold Onto More of It When You're Living with MS with Beth Scott and Paula Cole

Living with MS is expensive. Very expensive. It's estimated that the average cost of living with MS is over $88,000 per year. How, in the midst of financial stress and uncertainty, can you formulate a...

11 Aug 202529min

Episode 414: Finding Peace in the Midst of Uncertainty with Andrea Arzt, LCSW, MSCS

Episode 414: Finding Peace in the Midst of Uncertainty with Andrea Arzt, LCSW, MSCS

Living with MS has always meant living with uncertainty. Left unchecked, that uncertainty can lead to anxiety, which can make your MS symptoms feel worse. This week, Licensed Clinical Social Wor...

4 Aug 202533min

Episode 413: How AI Will Impact MS Patient Care with Dr. Brad Willingham

Episode 413: How AI Will Impact MS Patient Care with Dr. Brad Willingham

We're witnessing the early stages of a paradigm shift, as artificial intelligence is beginning to impact virtually every aspect of healthcare, from research to patient care. And there's much, much mor...

28 Juli 202534min

Episode 412: Understanding Late-Onset MS with Dr. Jacqueline Nicholas

Episode 412: Understanding Late-Onset MS with Dr. Jacqueline Nicholas

More people over the age of 50 are being diagnosed with MS than ever before. When you consider the other health conditions that often develop as we age, and you add the fact that our immune system cha...

21 Juli 202530min

Episode 411: An Encouraging Clinical Trial for Progressive MS with Jason Tardio

Episode 411: An Encouraging Clinical Trial for Progressive MS with Jason Tardio

Back in Episode #401, we reported promising results from a Phase 2 clinical trial for vidofludimus calcium and its impact on progressive MS. This therapy is being developed by Immunic Therapeutics, an...

14 Juli 202531min

Episode 410: From the International Progressive MS Alliance Digital Tools Workshop -- Part Two

Episode 410: From the International Progressive MS Alliance Digital Tools Workshop -- Part Two

Over the past few months, we've shared news about an algorithm that can accurately predict whether someone living with MS will experience worsening symptoms or a relapse in the weeks ahead. You've hea...

7 Juli 202544min

Episode 409: From the International Progressive MS Alliance Digital Tools Workshop

Episode 409: From the International Progressive MS Alliance Digital Tools Workshop

Last week, I was in Philadelphia, attending the Digital Tools Workshop hosted by the International Progressive MS Alliance. Welcome to Part One of our coverage! As we look around us, it's hard to i...

30 Juni 202539min

Episode 408: Explaining Your MS to All Those Well-Meaning Family Members and Friends Who Get It Wrong with Kris Inman

Episode 408: Explaining Your MS to All Those Well-Meaning Family Members and Friends Who Get It Wrong with Kris Inman

Have you experienced those familiar feelings of frustration when the people closest to you don't seem to get your MS? Do you find yourself explaining and re-explaining things to well-meaning friends, ...

23 Juni 202530min

Populärt inom Hälsa

somna-med-henrik
rss-jossan-nina
rss-bara-en-till-om-missbruk-medberoende-2
inga-beiga-morsor
alska-oss
johannes-hansen-podcast
not-fanny-anymore
rss-vuxna-pa-latsas
rss-viktmedicinpodden
sexnoveller-deluxe
angestpodden
sova-med-dan-horning
sa-in-i-sjalen
rss-psykoterapipodden
brottarbroder
giggles-med-wiggles
rss-aldrig-lagom
rss-basta-livet
rss-sjalsligt-avkladd
smartare-fitness-podden